Project Grant R03HG013341

Award Date 9/23/24
Completion Date 8/31/26
Dollars Obligated $161K
Federal Grant Program
93.172
Assistance Type
Project Grant
Place of Performance
Rochester, MN 55905, USA
Similar Awards
The National Human Genome Research Institute (NHGRI) awarded a $993,446 Project Grant (CFDA 93.172 - Human Genome Research) to the Sloan-Kettering Institute for Cancer Research in New York. The grant, awarded on May 1, 2025, will fund the development of statistical and machine learning approaches to decode the regulatory activity underlying disease variants, link variants to genes in relevant cell types, and identify disease-critical cooperative programs of genes and genomic elements. Key...
The National Human Genome Research Institute (NHGRI) awarded a $259,446 Project Grant under CFDA Program 93.172 - Human Genome Research to the University of Washington. The grant, effective September 4, 2024 through June 30, 2025, will fund the development of semi-supervised machine learning integration tools to predict undercharacterized genomic and proteomic data from single-cell profiling. The research aims to computationally fill gaps in single-cell time series data, predict the physical...
The National Human Genome Research Institute (NHGRI) awarded a $486,000 Project Grant (CFDA 93.172 - Human Genome Research) to The Johns Hopkins University to develop a Genomic Medicine Master of Science (M.S.) degree program. The program will provide advanced training to prepare health professionals and trainees with the knowledge and skills required to manipulate, annotate, and interpret human genome data, as well as a foundation for pursuing genomics research. The project leverages the...
This Project Grant award, valued at $491,366, was issued by the National Human Genome Research Institute (NHGRI) under the Human Genome Research federal grant program (CFDA 93.172). The award is focused on developing new algorithms to robustly map disease-associated genetic variants to critical target genes, particularly in underrepresented populations. Key objectives include: Improving the ability to identify disease-critical genes in non-European populations where data is limited. Developing...
The National Human Genome Research Institute (NHGRI) awarded a $666,831 Project Grant under CFDA 93.172 (Human Genome Research) to The Leland Stanford Junior University. The grant, titled "Bayesian Estimation of Gene Effects on Traits from Coding Variants", aims to develop new techniques for using rare protein-coding variants, including loss-of-function mutations, deletions, and duplications, in burden tests to estimate the magnitude and direction of effect of each gene on a...
The National Human Genome Research Institute (NHGRI) awarded a $579,698 Project Grant (CFDA 93.172 - Human Genome Research) to the Fred Hutchinson Cancer Center in Seattle, Washington to develop the "FACETING GEMS (Genomic Education Modules) for the Entry-Level Workforce" program. The program aims to address the gap in genomics education at under-resourced community colleges by: 1) Providing accessible, research-focused genomics training modules; 2) Training and motivating partner site...
The National Human Genome Research Institute (NHGRI) awarded a $594,501 Project Grant (CFDA 93.172 - Human Genome Research) to Cold Spring Harbor Laboratory to develop a unified probabilistic model and software implementation for analyzing nascent RNA sequencing data. The project aims to create powerful computational tools that can accelerate transcriptional research by enabling the estimation of transcriptional rates directly from nascent RNA sequencing data, with applications in areas such...
The National Human Genome Research Institute (NHGRI) awarded a $135,622 Project Grant (CFDA 93.172 Human Genome Research) to The Johns Hopkins University on September 19, 2024. The purpose of this grant is to develop Genomics Educational Modules (GEMs) for entry-level medical and research personnel in order to boost diversity and increase equity in the field of genomics. The GEMs will cover topics such as genetics and genomics of cardiovascular conditions, cancer, reproductive healthcare,...
The National Human Genome Research Institute (NHGRI) awarded a $470,250 Project Grant (CFDA 93.172 - Human Genome Research) to Children's Hospital Los Angeles (CHLA) to explore the perspectives of diverse parents on issues related to pediatric genome testing, research, and data management. The award will fund a qualitative pilot study utilizing focus groups, interviews, and a survey to: (1) examine attitudes towards genome sequencing for clinical testing and research with a focus on...
This federal Project Grant award from the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172) will support a $1,149,164 research project led by the Hastings Center Inc. to investigate ethical and policy challenges facing the gene therapy ecosystem. The project aims to: 1) analyze policy documents and conduct surveys and interviews with key experts to characterize the challenges in obtaining evidence for FDA approval, establishing coverage...

This Project Grant award, valued at $161,400.00 and running from September 23, 2024 to August 31, 2026, was provided by the National Human Genome Research Institute (NHGRI) under the Human Genome Research federal grant program (CFDA 93.172). The award will support research to empirically validate one or more standards-based models that can help make permissions for biospecimen sharing and reuse understandable to machines. This innovative research aims to respect and protect biospecimen contributors' autonomous choices, promote transparency in how those choices are communicated, and enhance responsible stewardship of biospecimens and information. The project will involve examining four established machine-interpretable models for expressing permissions, restrictions, and obligations related to biospecimen and data sharing and reuse. The research will be conducted by the Mayo Clinic, a renowned non-profit academic medical center in Rochester, Minnesota.

Generated 7/1/25, 2:06 AM